The AI in precision medicine market shows strong growth prospects driven by the need for personalized therapies amid rising chronic diseases. Key opportunities include advancements in AI for ...

A new artificial intelligence system called DeepRare has beaten experienced rare-disease physicians at their own specialty, ...

The simulator takes into account forecasted demand in each region, transportation costs, and the operational capacity of each warehouse.

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

The seven-year medical odyssey that once defined rare disease diagnosis is being rewritten by algorithms capable of identifying medical zebras in the time it takes to refresh your social media feed.

AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...

Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to identifying genetic perturbation patterns in cell images – potentially enabling ...

AI is only as good as the data it learns from. Right now, research suggests 73% of health data in AI comes from North America ...